Clinical trials explained: Why colour matters…
November 8, 2023 |
Colour can be used to emphasise mood, evoke emotions, and determine first impressions of a brand. Find how to use colour effectively in your next clinical trial campaign.
Just like any product or service, a clinical trial is essentially a brand. It has objectives, a ‘personality’, and a look that helps it to be recognisable and, therefore, trusted. Trial branding also needs to resonate, and empathise, with those people who might take part.
As is the same with all brands, colour plays an important role in creating its identity. Our association with brand colours runs through every aspect of our lives. Think of the red of Coca-Cola, the purple of Cadbury and the blue of the NHS. Barbie pink, anyone?
Colour can be used to emphasise mood, evoke emotions, and determine first impressions of a brand. So, ready to learn a bit more about how colour can help your next clinical trial campaign to stand out and connect with the people who matter?
The psychology of colour
This is where colour psychology (how colours can affect perceptions and behaviour) comes in useful.
For centuries, colour has been used for its therapeutic properties; blues and greens to calm and reassure, yellows and reds to provoke excitement and happiness. But, while there are some common responses to colours, it’s rarely that simple — many things affect how people react. When creating a brand for your trial, patient insights can help to shine a torch on what patients are thinking, their concerns, and what’s important to them. Our experience at Cuttsy+Cuttsy has shown that this can be influenced by many factors, and that paying close attention to them really does pay off.
Using a branding model can help (you can see ours here). Patient insights can be used to shape a trial’s personality and identify the emotions that participants might associate with the study: supported, altruistic, comforted, intrigued, and so on.
What’s the context?
Different colours evoke different emotions and, depending on the context, they can make materials stand out or blend in. Our association with certain colours — and shades — can also influence how appropriate they may be for clinical materials.
There are no hard and fast rules for the use of colour; it’s about what connects with patients. So, it’s crucial to revisit the brand model and assess the impact of colour for your audience.
Colour for everyone
Once an initial palette has been selected for your clinical trial, there are some practical matters to consider. Colour blindness, visual impairments, neurodiversity and even some medications can affect how an individual perceives colour. At Cuttsy+Cuttsy, we carefully consider colour psychology, together with other design elements, when working with our partners to finalise the branding colours for their clinical trials.
Understanding the power of colour and marrying it with the needs and perceptions of potential participants is a key part of clinical trial identity, personality, and gravitas. Is this something you would like to explore for your next clinical trial? If so, and you’d like a colour consultation, let’s talk.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
New report now available: Integrating ‘patient first’ into medicine development
A new report has just been published by Cuttsy+Cuttsy that collates all the current best thinking in the ‘patient first’ space, distilling it into a practical and actionable road map...
The digital prescription – enhancing the patient experience with technology
We explore how digital health innovations are revolutionising patient care by enhancing accessibility, personalisation, and engagement, promising a more connected and empowered patient experience.
Compliance — a driving force for influencing public perceptions of the pharma industry?
How does compliance play into public perceptions of pharma and why is it important for improving public opinion?
Another year, another B!
Louise Jones, Cuttsy+Cuttsy's Sustainability Officer reflects on their latest year of carbon reporting through CDP and on achieving another B rating.
Jon Hume Joins Cuttsy+Cuttsy as New Commercial Director
Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.
Clinical trial considerations: Why supporting HCPs matters…
When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone.
Clinical trial considerations: Why diversity matters…
Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...
Clinical trial considerations: Why digital matters…
Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.
Clinical trials explained: Why imagery matters…
Recruiting patients for clinical trials is one of pharma's greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the...
Clinical trials explained: Why health literacy matters…
Clinical trial recruitment can be a challenge. By applying the principles of health literacy to all materials, we can support people to make an informed choice about whether to take...